+Compare
TMO
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
194.05B

TMO Price Prediction, Thermo Fisher Scientific AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for TMO with price predictions
08:00 PM EDT Sep 21, 2023

TMO's Stochastic Oscillator stays in oversold zone for 11 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMO advanced for three days, in of 366 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 07, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on TMO as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TMO turned negative on September 07, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

TMO moved below its 50-day moving average on September 06, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TMO crossed bearishly below the 50-day moving average on September 12, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TMO broke above its upper Bollinger Band on August 29, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TMO entered a downward trend on August 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TMO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.435) is normal, around the industry mean (24.975). P/E Ratio (34.364) is within average values for comparable stocks, (79.203). Projected Growth (PEG Ratio) (1.940) is also within normal values, averaging (6.228). Dividend Yield (0.003) settles around the average of (0.019) among similar stocks. P/S Ratio (4.517) is also within normal values, averaging (58.475).

A.I. Advisor
published Earnings

TMO is expected to report earnings to rise 10.49% to $5.69 per share on October 25

Thermo Fisher Scientific TMO Stock Earnings Reports
Q3'23
Est.
$5.69
Q2'23
Missed
by $0.28
Q1'23
Est.
$5.03
Q4'22
Beat
by $0.18
Q3'22
Beat
by $0.25
The last earnings report on July 26 showed earnings per share of $5.15, missing the estimate of $5.43. With 98.75K shares outstanding, the current market capitalization sits at 194.05B.
A.I.Advisor
published Dividends

TMO is expected to pay dividends on October 13, 2023

Thermo Fisher Scientific TMO Stock Dividends
A dividend of $0.35 per share will be paid with a record date of October 13, 2023, and an ex-dividend date of September 14, 2023. The last dividend of $0.35 was paid on July 14. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.31B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -3%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -7%. AVGR experienced the highest price growth at 135%, while HSCS experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -40%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was 38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 67
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of analytical and environment monitoring instruments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
168 Third Avenue
Phone
+1 781 622-1000
Employees
130000
Web
https://www.thermofisher.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MFA10.200.14
+1.39%
MFA Financial
MRDB0.47N/A
+0.89%
MariaDB plc
SNV27.830.10
+0.36%
Synovus Financial Corp
MET64.42-0.27
-0.42%
MetLife
SCLX1.58-0.17
-9.71%
Scilex Holding Company

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
+0.24%
DHR - TMO
83%
Closely correlated
-0.50%
A - TMO
79%
Closely correlated
+1.53%
WAT - TMO
76%
Closely correlated
+0.05%
MTD - TMO
72%
Closely correlated
+0.55%
IQV - TMO
68%
Closely correlated
-0.22%
More